What Happened
Regulation Debate Heats Up Amid Global Tech Shift
The White House is experiencing a tug-of-war over AI policy, with chief of staff Susie Wiles walking back comments from an administration official that the government would regulate AI models like FDA drugs. This development highlights the ongoing debate over AI regulation and its potential impact on the tech industry. The European Union has also established a new AI delegation, and research into fine-tuning AI models is underway. This news was first reported by The Washington Post.